A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2011
10/18/2011	CA2579207C Morpholine compound
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2470643C Cleavable reagents for specific delivery to disease sites
10/18/2011	CA2470199C Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
10/18/2011	CA2446189C Peptides and related molecules that bind to tall-1
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/18/2011	CA2337328C Biocompatible polymers, preparation method and compositions containing same
10/13/2011	WO2011127090A1 Conditioned medium obtained form stem cells and its use in therapy
10/13/2011	WO2011126384A1 Honey-based gel composition
10/13/2011	WO2011125763A1 Preventive and/or remedy for hand and foot syndrome
10/13/2011	WO2011072216A9 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
10/13/2011	WO2011050947A3 Tape, in particular, adhesive tape, for the treatment of skin disorders comprising at least one hyperkeratosis inhibitor and/or at least one keratinolytic agent
10/13/2011	WO2011044207A3 Compositions containing a high concentration of polar sphingolipid(s)
10/13/2011	WO2007067036A3 New use of carbonic anhydrase inhibitors
10/13/2011	US20110251566 Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
10/13/2011	US20110251283 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/13/2011	US20110251279 Composition of Amino Acids for Sublingual Applying for Enhanced Skin Integument Repigmentation in Vitiligo and Method of its Administration
10/13/2011	US20110251251 Polymorph ii of an antifungal compound
10/13/2011	US20110251242 Photostabilization of resveratrol with alkoxycrylene compounds
10/13/2011	US20110251222 Sulfone-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as a medicine
10/13/2011	US20110251206 Squaramide derivatives as CXCR2 antagonist
10/13/2011	US20110251200 Aryl guanidine f1f0-atpase inhibitors and related methods
10/13/2011	US20110251197 Lysosomotropic inhibitors of acid ceramidase
10/13/2011	US20110251177 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251168 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/13/2011	US20110251144 Molecular modulators of the wnt/beta-catenin pathway
10/13/2011	US20110251140 Peptide antagonist of interleukin-15 activity
10/13/2011	US20110250302 Composition for Preventing Hair Loss and Promoting Hair Regrowth
10/13/2011	US20110250293 Present invention relates to compositions and methods for the treatment of topical skin conditions, comprising of shea butter, jojoba oil, dihydrogen oxide, Stearic acid, Anhydrous Magnesium Sulphate, Zinc Oxide, Glycerin and a suitable amount of a Pharmaceutically acceptable carrier, one or both of the following: Cocoa butter and or petroleum jelly.
10/13/2011	US20110250291 Use of arsenic for cancer therapy protection
10/13/2011	US20110250275 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
10/13/2011	US20110250270 Compositions containing a capillary-active system with application-relevant diffferentiability and their use
10/13/2011	US20110250257 Fibrous tissue sealant and method of using same
10/13/2011	US20110250240 Immune enhancing compositions and methods of use thereof
10/13/2011	US20110250239 Pharmaceutical and/or cosmetic composition for treating the skin
10/13/2011	US20110250227 Composition for treatment of the skin
10/13/2011	US20110250219 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
10/13/2011	US20110250215 Structurally-related relaxin-fusion proteins with extended in vivo half-lives
10/13/2011	US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/13/2011	US20110250193 Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
10/13/2011	US20110250186 Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell1
10/13/2011	US20110250167 Method for purifying proteins
10/13/2011	US20110250153 Oligomeric biosurfactants in dermatocosmetic compositions
10/13/2011	US20110250151 Cold process water soluble wax containing powders
10/13/2011	US20110250131 Antigens Associated with Endometriosis, Psoriatic Arthritis and Psoriasis
10/13/2011	CA2795520A1 Methods and compositions for treating wounds utilizing chitosan compounds
10/13/2011	CA2793354A1 Honey-based gel composition
10/12/2011	EP2374453A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
10/12/2011	EP2374449A2 Composition including at least one aqueous phase and at least one oil phase including ivermectin
10/12/2011	EP2373670A2 Novel amino substituted c-glycoside derivatives and use thereof as cosmetic
10/12/2011	EP2373325A1 Composition for preventing or treating alopecia
10/12/2011	EP2373321A1 Platelets lysate and bioadesive compositions thereof for the treatment of mucositis
10/12/2011	EP2373312A1 A composition for use on skin and wound
10/12/2011	EP2373304A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/12/2011	EP2373302A1 The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them
10/12/2011	EP2373281A2 Topical compositions containing coated active agents
10/12/2011	EP1893191B1 Medicinal acidic cannabinoids
10/12/2011	EP1807064B1 Cyanoacrylate monomer formulation containing diiodomethyl-p-tolylsulfone and hydroxydiphenyl ether
10/12/2011	EP1759683B1 Scalp and hair-care composition
10/12/2011	EP1525884B1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
10/12/2011	EP1448995B9 Assay for screening candidate drugs for the treatment of inflammatory diseases
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN102216318A Antioxidant
10/12/2011	CN102216273A Naphthylacetic acids used as crth2 antagonists or partial agonists
10/12/2011	CN102216265A Naphthylacetic acids
10/12/2011	CN102215858A Methods of treatment using single doses of oritavancin
10/12/2011	CN102215854A Extract of aerial parts of oats harvested before ear emergence
10/12/2011	CN102215833A Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
10/12/2011	CN102215812A Anti-wrinkle agents
10/12/2011	CN102212596A Preparation method of human epidermal growth factor
10/12/2011	CN102212447A Health-care wine
10/12/2011	CN102212438A Preparation method of beautifying and moistening lotion
10/12/2011	CN102212074A Cefonicid sodium hydrate and preparation method and application thereof
10/12/2011	CN102210855A Complex of marine oligosaccharides and collagen peptides, preparation method thereof and application thereof
10/12/2011	CN102210853A Method for preparing liposome containing EGFs (Epidermal Growth Factors) and transdermal short peptide fusion proteins, for controlling diabetic foot gangrene
10/12/2011	CN102210848A Medicament for treating skin disease, and preparation method thereof
10/12/2011	CN102210842A Chinese herbal lotion for treating dandruff
10/12/2011	CN102210830A Women skin-care liquor and preparation method thereof
10/12/2011	CN102210829A Multiflower knotweed tuber and mulberry health-care pill
10/12/2011	CN102210828A Chinese medicine capsule for treating psoriasis
10/12/2011	CN102210825A External applied medicine for treating beriberi and preparation method thereof
10/12/2011	CN102210811A Dark plum oral solution
10/12/2011	CN102210810A Medicament for treating alopecia
10/12/2011	CN102210809A Lotion for treating onychomycosis
10/12/2011	CN102210804A Medicament for treating psoriasis
10/12/2011	CN102210771A Medical formula for treating eczema and preparation method thereof
10/12/2011	CN102210749A Chinese medicinal preparation for treating eczematous dermitis of piglets
10/12/2011	CN102210746A Cream medicine composition and preparation method thereof
10/12/2011	CN102210739A Method for extracting total saponins and total flavonoids from alfalfa and preparation method thereof
10/12/2011	CN102210714A Application of earthworm in preparing chemotactic cytokines inducer
10/12/2011	CN102210713A Traditional Chinese medicine for treating child measles
10/12/2011	CN102210694A Oral amifostine preparation and preparation method thereof
10/12/2011	CN102210680A Sinomenine derivatives for treating inflammatory disease by blocking macrophage p38 MAPK (mitogen activated protein kinase) signal transduction pathway
10/12/2011	CN102210672A Application of polyketide in preparation of angiogenesis inhibiting medicine
10/12/2011	CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes
10/12/2011	CN102210651A Nitrofurazone washing fluid, preparation method and application thereof
10/12/2011	CN102210650A Prednicarbate emulsifiable paste and preparation method thereof
10/12/2011	CN102210649A Amphotericin B cream and preparation method thereof

1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 1065